Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: Eppendorf; SDIX; EMD Millipore; Addgene, MJFF

NEW YORK (GenomeWeb News) – Eppendorf this week opened its new UK headquarters in the Arlington Business Park in Stevenage. The new Eppendorf House is 9,500 square feet, more than doubling its previous capacity, and will include a demonstration area for both Eppendorf and New Brunswick brand products.


SDIX said this week that it has sold its food safety and GMO businesses to Romer Labs for $13.5 million. Newark, Del.-based SDIX said that it will now concentrate on its life science business and its Advanced GAT technologies.


EMD Millipore announced this week that it is providing The Breast Cancer Research Foundation with a four-year, $500,000 grant to support breast cancer biomarker, drug development, and personalized medicine research programs. The funding will come in the form of two grants of $250,000 administered over a two year period. The grants build on an alliance between EMD Millipore, the Billerica, Mass.-based division of Merck KGaA, and BCRF.


Non-profit Addgene announced a collaboration with the Michael J. Fox Foundation for Parkinson's Research to assemble a collection of plasmid DNA samples for use in Parkinson's research. The resource will be curated and distributed by Addgene to life science researchers around the world.


In Brief This Week is a Friday column containing news items that our readers may have missed during the week.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.